If you're one of the 65 percent of Americans with rosacea, you don't have to hide behind makeup. Rosacea is an inflammatory skin condition that affects 16 million Americans, so if you have it, you are not alone! More women than men have rosacea, and a whopping 82 percent of women use cosmetics to cover up the redness.
What is Rosacea?
Rosacea is caused by dilated blood vessels in the face, which causes increased blood flow. This in turn causes redness in your face. Fortunately, rosacea can be treated. Mirvaso Topical Gel from Galderma Laboratories, L.P. is the first and only gel treatment approved by the FDA for the treatment of persistent facial redness of rosacea.
Why You Should Break Up With Makeup
Most women use foundations and concealers to cover the redness. In fact, only 53 percent of American women wear makeup, but 77 percent of rosacea sufferers wear makeup. A single non-prescription product to hide facial redness costs and average of $36!
By comparison, Mirvaso is covered by most insurance plans for the cost of your copay. That could mean considerable savings depending on your insurance plan, and you could be free from makeup!
Once you start using Mirvaso, you can break up with your makeup! You won't have to buy expensive foundations, and you won't have to worry about reapplying them during the day. Do you want to go swimming? You can without worrying about your makeup.
Check out Mirvaso for more information and see how you can win a trip to the Emmy Award Show!
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Each gram of gel contains 5mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base